Please provide your email address to receive an email when new articles are posted on . AliveCor announced it received FDA 510(k) clearance for its mobile, handheld ECG device for the calculation of a ...
Researchers have been using artificial intelligence (AI) to develop a mobile device that can identify certain patients at risk of sudden cardiac death. Researchers from Mayo Clinic and AliveCor Inc.
Perhaps 40% of persons with genetically confirmed long-QT syndrome (LQTS) do not show the telltale electrocardiographic (ECG) feature, a prolonged heart-rate-corrected QT (QTc) interval, when their 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results